DexCom, Inc.
DXCM
$67.56
$1.231.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.84% | 70.59% | -30.52% | 12.70% | -6.20% |
| Total Depreciation and Amortization | 0.95% | 5.00% | -19.46% | 34.72% | 6.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 114.02% | 110.00% | -73.84% | 1,209.68% | -138.27% |
| Change in Net Operating Assets | 933.93% | 5,500.00% | -93.75% | -59.49% | -76.63% |
| Cash from Operations | 117.79% | 64.85% | -39.02% | 51.08% | -28.60% |
| Capital Expenditure | 14.45% | -8.16% | 30.18% | -12.05% | -68.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 796.07% | -83.71% | 204.52% | -155.71% | 361.81% |
| Cash from Investing | 403.14% | -163.47% | 132.99% | -244.41% | 211.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 0.00% | -6.25% | -23.08% | 7.14% |
| Cash from Financing | -10,194.12% | -113.60% | 881.25% | 99.78% | -52,507.14% |
| Foreign Exchange rate Adjustments | -106.67% | 617.39% | 120.54% | -230.23% | 960.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.17% | -14.93% | 2,078.81% | 95.25% | -461.07% |